Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ESCAP-2020-CPHG: Treatment Strategies Follow-up Implemented During the First Three Years Following Primary Lung Cancer (PLC) Diagnosed in KBP-2020-CPHG Cohort Patients

NCT04419155 is registered in ClinicalTrials.gov with Collège des Pneumologues des Hôpitaux Généraux as lead sponsor.

NCT NCT04419155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04419155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ESCAP-2020-CPHG: Treatment Strategies Follow-up Implemented During the First Three Years Following Primary Lung Cancer (PLC) Diagnosed in KBP-2020-CPHG Cohort Patients
Lead sponsor
Collège des Pneumologues des Hôpitaux Généraux
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2020
Completion date
December 31, 2023
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer